In the latest trading session,, 10.7 million Hims & Hers Health Inc (NYSE:HIMS) shares changed hands as the company’s beta touched 2.04. With the company’s most recent per share price at $49.11 changed hands at -$0.3 or -0.61% at last look, the market valuation stands at $10.99B. HIMS’s current price is a discount, trading about -48.61% off its 52-week high of $72.98. The share price had its 52-week low at $13.47, which suggests the last value was 72.57% up since then. When we look at Hims & Hers Health Inc’s average trading volume, we note the 10-day average is 63.96 million shares, with the 3-month average coming to 45.18 million.
Analysts gave the Hims & Hers Health Inc (HIMS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.64. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 5 recommended HIMS as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Instantly HIMS was in red as seen in intraday trades today. With action 16.98%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 127.78%, with the 5-day performance at 16.98% in the green. However, in the 30-day time frame, Hims & Hers Health Inc (NYSE:HIMS) is -6.28% down. Looking at the short shares, we see there were 61.69 million shares sold at short interest cover period of 1.47 days.
The consensus price target for the stock as assigned by Wall Street analysts is 55, meaning bulls need an upside of 10.71% from its recent market value. According to analyst projections, HIMS’s forecast low is 30 with 68 as the target high. To hit the forecast high, the stock’s price needs a -38.46% plunge from its current level, while the stock would need to tank 38.91% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.22%. The 2025 estimates are for Hims & Hers Health Inc earnings to increase by 27.49%, but the outlook for the next 5-year period is at 34.58% per year.
HIMS Dividends
Hims & Hers Health Inc is expected to release its next quarterly earnings report on 2025-May-05.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.13% of Hims & Hers Health Inc shares while 74.68% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 84.04%. There are 74.68% institutions holding the Hims & Hers Health Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 7.6746% of the shares, roughly 16.47 million HIMS shares worth $332.55 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.7907% or 14.57 million shares worth $294.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Apr 30, 2025 were iShares Trust-iShares Core S&P Mid-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . With 6.19 shares estimated at $305.93 million under it, the former controlled 2.87% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held about 2.54% of the shares, roughly 5.47 shares worth around $270.11 million.
